[The course of coronary heart disease and quality of life in patients with anxiety of different degree].
OBJECTIVE
To study an emotional status and quality of life (QL) in patients with coronary heart disease (CHD) and anxiety, to evaluate efficacy of anxiolytic drug lorazepam (lorafen) in such patients.


METHODS
Anxiety in 277 CHD patients was assessed by hospital scale of anxiety and depression, depression--by Beck's questionnaire, QL--by Seattle questionnaire.


RESULTS
CHD patients with clinically significant anxiety had more serious vegetative disorders, worse QL and prognosis. Lorazepam treatment improved both emotional state of the patients and QL.


CONCLUSIONS
High prevalence of anxious disorders in CHD patients deteriorating QL and prognosis dictates the necessity of detecting and treating anxiety in CHD patients.
Ibatov
A D
AD
D000328:Adult; D000368:Aged; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D001007:Anxiety / Q000188:drug therapy / Q000209:etiology / Q000523:psychology*; D003327:Coronary Disease / Q000150:complications / Q000503:physiopathology / Q000523:psychology*; D004644:Emotions / Q000502:physiology*; D005260:Female; D006801:Humans; D008140:Lorazepam / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011788:Quality of Life; D012720:Severity of Illness Index; D011795:Surveys and Questionnaires
D014151:Anti-Anxiety Agents; D008140:Lorazepam